Lucid Diagnostics Inc. Preferred Stock Dividends and Other Adjustments
Lucid Diagnostics Inc. (LUCD) reported Preferred Stock Dividends and Other Adjustments of $3.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2026-08-12
- Lucid Diagnostics Inc. preferred stock dividends and other adjustments for the quarter ending 2026-06-30 was $3.03M, a 12.21% decline year-over-year.
- Lucid Diagnostics Inc. preferred stock dividends and other adjustments for the quarter ending 2026-03-31 was $9.72M, a 6.68% increase year-over-year.
- Lucid Diagnostics Inc. preferred stock dividends and other adjustments for the quarter ending 2025-06-30 was $3.45M.
- Lucid Diagnostics Inc. preferred stock dividends and other adjustments for the quarter ending 2025-03-31 was $9.11M, a 21.53% increase year-over-year.
- Lucid Diagnostics Inc. preferred stock dividends and other adjustments for fiscal 2024 was $7.50M.
| Period end | Preferred Stock Dividends and Other Adjustments | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.03M 10-Q · filed 2026-08-12 | $12.75M 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | $9.72M 10-Q · filed 2026-05-13 | ||||
| 2025-06-30 | $3.45M 10-Q · filed 2026-08-12 | $12.56M 10-Q · filed 2026-08-12 | $12.56M derived: sum of 3 quarters · filed 2026-08-12 | $12.56M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $9.11M 10-Q · filed 2026-05-13 | $9.11M derived: sum of 2 quarters · filed 2026-05-13 | $9.11M derived: sum of 3 quarters · filed 2026-05-13 | $9.11M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 derived: sum of 3 quarters · filed 2025-11-12 | $7.50M 10-K · filed 2025-03-24 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $7.50M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $7.50M 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | $7.50M 10-Q · filed 2025-05-13 | ||||
| 2024-03-13 | $7.50M 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |